Drug Side Effects
Search
OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC
OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC
was reported 19 times
OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Hedgehog Pathway Inhibitor [EPC]
1
0.0001
1
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
2
Interleukin-17A Antagonist [EPC]
1
0.0000
3
Platinum-based Drug [EPC]
7
0.0000
4
Nucleoside Analog Antiviral [EPC]
2
0.0000
5
Protease Inhibitor [EPC]
1
0.0000
6
Programmed Death Receptor-1 Blocking Antibody [EPC]
2
0.0000
7
Microtubule Inhibitor [EPC]
3
0.0000
8
Cytochrome P450 3A Inhibitor [EPC]
1
0.0000
9
Nucleoside Metabolic Inhibitor [EPC]
4
0.0000
10
Dietary Cholesterol Absorption Inhibitor [EPC]
1
0.0000
11
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
12
Histamine-2 Receptor Antagonist [EPC]
1
0.0000
13
Azole Antifungal [EPC]
1
0.0000
14
Proton Pump Inhibitor [EPC]
2
0.0000
15
Vitamin D [EPC]
1
0.0000
16
Vitamin B12 [EPC]
1
0.0000
17
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
18
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
19
Vitamin C [EPC]
1
0.0000
20
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
21
GLP-1 Receptor Agonist [EPC]
1
0.0000
22
Loop Diuretic [EPC]
1
0.0000
23
Thalidomide Analog [EPC]
1
0.0000
24
Tumor Necrosis Factor Blocker [EPC]
1
0.0000